Concepedia

Vijay T. Ahuja

VT

Statistics

Publications

16

Citations

426

H-Index

14

Active since

2004

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (India)

Biocon (India)

Lexicon Pharmaceuticals (United States)

Vijay T. Ahuja is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

2004–2023

16

Publications

16

A Strategy to Minimize Reactive Metabolite Formation: Discovery of (<i>S</i>)-4-(1-Cyclopropyl-2-methoxyethyl)-6-[6-(difluoromethoxy)-2,5-dimethylpyridin-3-ylamino]-5-oxo-4,5-dihydropyrazine-2-carbonitrile as a Potent, Orally Bioavailable Corticotropin-Releasing Factor-1 Receptor Antagonist

Richard A. Hartz, Vijay T. Ahuja, Xiaoliang Zhuo et al. · Journal of Medicinal Chemistry · 2009 · 54 citations · Full text

, , +17

Discovery and Preclinical Pharmacology of an Oral Bromodomain and Extra-Terminal (BET) Inhibitor Using Scaffold-Hopping and Structure-Guided Drug Design

Ashvinikumar V. Gavai, Derek Norris, George V. Delucca et al. · Journal of Medicinal Chemistry · 2021 · 44 citations · Full text

, , +17

In Vitro Intrinsic Clearance-Based Optimization of<i>N</i><sup>3</sup>-Phenylpyrazinones as Corticotropin-Releasing Factor-1 (CRF<sub>1</sub>) Receptor Antagonists

Richard A. Hartz, Vijay T. Ahuja, Maria Rafalski et al. · Journal of Medicinal Chemistry · 2009 · 38 citations · Full text

, , +16

Discovery of Non-Nucleotide Small-Molecule STING Agonists <i>via</i> Chemotype Hybridization

Emily C. Cherney, Liping Zhang, Julian B. Lo et al. · Journal of Medicinal Chemistry · 2022 · 34 citations · Full text

, , +16

Synthesis, Structure−Activity Relationships, and In Vivo Evaluation of<i>N</i><sup>3</sup>-Phenylpyrazinones as Novel Corticotropin-Releasing Factor-1 (CRF<sub>1</sub>) Receptor Antagonists

Richard A. Hartz, Vijay T. Ahuja, Argyrios G. Arvanitis et al. · Journal of Medicinal Chemistry · 2009 · 33 citations · Full text

, , +11

1–5 of 16